The physical basis of FGFR3 response to fgf1 and fgf2

Biochemistry

Volumn 50, Issue 40, 2011, Pages 8576-8582

  Chen, Fenghao ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION LOOPS; ALTERNATIVE SPLICING; BIOLOGICAL RESPONSE; BONE DEVELOPMENT; EMBRYONIC DEVELOPMENT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTORS; GAIN INSIGHT; ISOFORMS; MEMBRANE RECEPTORS;

AMINO ACIDS; CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; GROWTH KINETICS; PHOSPHORYLATION;

PEPTIDES;

DIMER; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; MEMBRANE RECEPTOR; TYROSINE;

ARTICLE; BONE DEVELOPMENT; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

CELL LINE; DIMERIZATION; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HUMANS; KINETICS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION;

EID: 80053578487     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi200986f     Document Type: Article

References (46)

1. Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev. 16, 139-149 (Pubitemid 40616112)
2. Wilkie, A. O. M., Morriss-Kay, G. M., Jones, E. Y., and Heath, J. K. (1995) Functions of fibroblast growth factors and their receptors Curr. Biol. 5, 500-507
3. Ornitz, D. M. and Itoh, N. (2001) Fibroblast growth factors Genome Biol. 2
4. GOSPODAR, D. (1974) Localization of A Fibroblast Growth-Factor and Its Effect Alone and with Hydrocortisone on 3T3 Cell-Growth Nature 249, 123-127
5. Gospodarowicz, D. (1975) Purification of A Fibroblast Growth-Factor from Bovine Pituitary J. Biol. Chem. 250, 2515-2520
6. Gospodarowicz, D., Bialecki, H., and Greenburg, G. (1978) Purification of Fibroblast Growth-Factor Activity from Bovine Brain J. Biol. Chem. 253, 3736-3743 (Pubitemid 8346572)
7. Maciag, T., Cerundolo, J., Ilsley, S., Kelley, P. R., and Forand, R. (1979) Endothelial Cell-Growth Factor from Bovine Hypothalamus-Identification and Partial Characterization Proc. Natl. Acad. Sci. U. S. A. 76, 5674-5678 (Pubitemid 10168670)
8. Mignatti, P., Morimoto, T., and Rifkin, D. B. (1992) Basic Fibroblast Growth-Factor, A Protein Devoid of Secretory Signal Sequence, Is Released by Cells Via A Pathway Independent of the Endoplasmic-Reticulum Golgi-Complex J. Cell. Physiol. 151, 81-93
9. Prudovsky, I., Tarantini, F., Landriscina, M., Neivandt, D., Soldi, R., Kirov, A., Small, D., Kathir, K. M., Rajalingam, D., and Kumar, T. K. S. (2008) Secretion without Golgi J. Cell. Biochem. 103, 1327-1343 (Pubitemid 351490704)
10. Moscatelli, D. (1987) High and Low Affinity Binding-Sites for Basic Fibroblast Growth-Factor on Cultured-Cells-Absence of A Role for Low Affinity Binding in the Stimulation of Plasminogen-Activator Production by Bovine Capillary Endothelial-Cells J. Cell. Physiol. 131, 123-130 (Pubitemid 17067272)
11. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. (1992) Heparin Is Required for Cell-Free Binding of Basic Fibroblast Growth-Factor to A Soluble Receptor and for Mitogenesis in Whole Cells Mol. Cell. Biol. 12, 240-247
12. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991) Cell-Surface, Heparin-Like Molecules Are Required for Binding of Basic Fibroblast Growth-Factor to Its High-Affinity Receptor Cell 64, 841-848 (Pubitemid 121001170)
13. Lin, X. H., Buff, E. M., Perrimon, N., and Michelson, A. M. (1999) Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development Development 126, 3715-3723 (Pubitemid 29440471)
14. Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., and Mohammadi, M. (1999) Structural basis for FGF receptor dimerization and activation Cell 98, 641-650 (Pubitemid 29418955)
15. Plotnikov, A. N., Hubbard, S. R., Schlessinger, J., and Mohammadi, M. (2000) Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity Cell 101, 413-424
16. Mohammadi, M., Olsen, S. K., and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation Cytokine Growth Factor Rev. 16, 107-137 (Pubitemid 40616111)
17. Ornitz, D. M. (2000) FGFs, heparan sulfate and FGFRs: complex interactions essential for development BioEssays 22, 108-112 (Pubitemid 30092077)
18. L'Horte, C. G. M. and Knowles, M. A. (2005) Cell responses to FGFR3 signaling: growth, differentiation and apoptosis. Experim Cell Res. 304, 417-431 (Pubitemid 40321120)
19. Ibrahimi, O. A., Zhang, F. M., Eliseenkova, A. V., Itoh, N., Linhardt, R. J., and Mohammadi, M. (2004) Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities Hum. Mol. Genet. 13, 2313-2324 (Pubitemid 39359928)
20. Ibrahimi, O. A., Zhang, F. M., Eliseenkova, A. V., Linhardt, R. J., and Mohammadi, M. (2004) Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity Hum. Mol. Genet. 13, 69-78 (Pubitemid 38072136)
21. Ornitz, D. M., Xu, J. S., Colvin, J. S., Mcewen, D. G., MacArthur, C. A., Coulier, F., Gao, G. X., and Goldfarb, M. (1996) Receptor specificity of the fibroblast growth factor family J. Biol. Chem. 271, 15292-15297 (Pubitemid 26195013)
22. Zhang, X. Q., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., and Ornitz, D. M. (2006) Receptor specificity of the fibroblast growth factor family-The complete mammalian FGF family J. Biol. Chem. 281, 15694-15700 (Pubitemid 43848456)
23. Olsen, S. K., Ibrahimi, O. A., Raucci, A., Zhang, F. M., Eliseenkova, A. V., Yayon, A., Basilico, C., Linhardt, R. J., Schlessinger, J., and Mohammadi, M. (2004) Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity Proc. Natl. Acad. Sci. U. S. A. 101, 935-940 (Pubitemid 38160562)
24. Radvanyi, F., Thiery, J. P., Billerey, C., van der Kwast, T. H., Zafrani, E. S., and Chopin, D. (2001) Fibroblast growth factor receptor: from chondrodysplasia to bladder cancer M S-Med. Sci. 17, 1189-1191 (Pubitemid 33368621)
25. Vajo, Z., Francomano, C. A., and Wilkin, D. J. (2000) The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans Endocrine Rev. 21, 23-39 (Pubitemid 32260394)
26. Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia Cell 78, 335-342 (Pubitemid 24241100)
27. Bellus, G. A., Mcintosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., Greenhaw, G. A., Hecht, J. T., and Francomano, C. A. (1995) A Recurrent Mutation in the Tyrosine Kinase Domain of Fibroblast Growth-Factor Receptor-3 Causes Hypochondroplasia Nature Genet. 10, 357-359
28. Naski, M. C., Wang, Q., Xu, J. S., and Ornitz, D. M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia Nature Genet. 13, 233-237 (Pubitemid 26166160)
29. Cho, J. Y., Guo, C. S., Torello, M., Lunstrum, G. P., Iwata, T., Deng, C. X., and Horton, W. A. (2004) Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia Proc. Natl. Acad. Sci. U. S. A. 101, 609-614 (Pubitemid 38084684)
30. Guo, C. S., Degnin, C. R., Laederich, M. B., Lunstrum, G. P., Holden, P., Bihimaier, J., Krakow, D., Cho, Y. J., and Horton, W. A. (2008) Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia Cell. Signalling 20, 1471-1477
31. He, L., Horton, W. A., and Hristova, K. (2010) The physical basis behind achondroplasia, the most common form of human dwarfism J. Biol. Chem. 285, 30103-30114
32. Li, E., You, M., and Hristova, K. (2006) FGFR3 dimer stabilization due to a single amino acid pathogenic mutation J. Mol. Biol. 356, 600-612 (Pubitemid 43139323)
33. You, M., Spangler, J., Li, E., Han, X., Ghosh, P., and Hristova, K. (2007) Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers Biochemistry 46, 11039-11046 (Pubitemid 47502770)
34. You, M., Li, E., and Hristova, K. (2006) The achondroplasia mutation does not alter the dimerization energetics of FGFR3 transmembrane domain Biochemistry 45, 5551-5556 (Pubitemid 43673185)
35. Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O., and Yayon, A. (2000) The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation Mol. Cell. Biol. 20, 516-522 (Pubitemid 30023093)
36. Monsonego-Ornan, E., Adar, R., Rom, E., and Yayon, A. (2002) FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation FEBS Lett. 528, 83-89 (Pubitemid 35258004)
37. Adar, R., Monsonego-Ornan, E., David, P., and Yayon, A. (2002) Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization J. Bone Miner. Res. 17, 860-868 (Pubitemid 34441903)
38. He, L., Wimley, W. C., and Hristova, K. (2011) FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism J. Biol. Chem. 286, 13272-13281
39. Chellaiah, A., Yuan, W. L., Chellaiah, M., and Ornitz, D. M. (1999) Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules-Multiple regions determine ligand binding specificity J. Biol. Chem. 274, 34785-34794 (Pubitemid 129509522)
40. He, L. and Hristova, K. (2008) Pathogenic activation of receptor tyrosine kinases in mammalian membranes J. Mol. Biol. 384, 1130-1142
41. Harmer, N. J. (2006) Insights into the role of heparan sulphate in fibroblast growth factor signalling Biochem. Soc. Trans. 34, 442-445 (Pubitemid 43954007)
42. Chen, F., Degnin, C., Laederich, M. B., Horton, A. W., and Hristova, K. (2011) The A391E mutation enhances FGFR3 activation in the absence of ligand Biochim. Biophys. Acta, Biomembr. 1808, 2045-2050
43. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M., and Schlessinger, J. (1996) Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction Mol. Cell. Biol. 16, 977-989 (Pubitemid 26061669)
44. Raffioni, S., Zhu, Y. Z., Bradshaw, R. A., and Thompson, L. M. (1998) Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation J. Biol. Chem. 273, 35250-35259 (Pubitemid 29028232)
45. Zhang, X. W., Gureasko, J., Shen, K., Cole, P. A., and Kuriyan, J. (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor Cell 125, 1137-1149 (Pubitemid 43866200)
46. Bae, J. H., Boggon, T. J., Tome, F., Mandiyan, V., Lax, I., and Schlessinger, J. (2010) Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells Proc. Natl. Acad. Sci. U. S. A. 107, 2866-2871